News
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the ...
Mini meals with bite size portions are meant to appeal to people taking GLP-1 weight-loss drugs that reduce appetite.
The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...
Dr. David Kessler, who led the FDA and later ran Operation Warp Speed, said obesity rates have jumped from 13% in the 1960s to 42% today because of what he calls “ultraformulated foods” that ...
The first, provocatively, is about the addictive power of food. This way of viewing food underpins the rest of the book. Part 2 explains the complex biology of weight gain and loss.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results